Autopsy report · NCT00554814

Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency

“insufficient recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 249 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Bledina

Sponsor type

Industry

Conditions

Latent Iron Deficiency

Interventions

Bledilait Biofer®; Milk supplemented with ferrous sulphate; Blédilait Biofer®

Participants

249 (planned, not actual)

Sites

1

Countries

France

Trials that died the same way

• Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery
  “Recruitment insufficient” (96% match in meaning)
• Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
  “not enough recruitment” (91% match in meaning)
• Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens
  “Insufficient recruitment population.” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.